Performance Status
2 clinical trials · Condition
| Record | Firm | Date |
|---|---|---|
| A Safety/Tolerance Phase, Ascending Single Dose Study to Evaluate the Safety and Tolerability of G3P-01, a Food-Grade Pectic Product, in Healthy Volunteers (NCT05296083) | SQ Innovation, Inc. | 2022-03-17 |
| Pilot Study of Performance Status 2 vs. Performance Status 0-1 Non-small Cell Lung Cancer Patients Treated With Chemo/Immunotherapy (NCT04253964) | Wake Forest University Health Sciences | 2020-07-01 |
Track Performance Status automatically
Every clearance here is in the API, with alerts when new ones post.